We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.42%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$29.6B
AUM Growth
+$1.62B
Cap. Flow
+$1.32B
Cap. Flow %
4.47%
Top 10 Hldgs %
15.49%
Holding
3,030
New
705
Increased
1,212
Reduced
975
Closed
103

Sector Composition

Rank Sector Weight
1 Healthcare 9.02%
2 Technology 8.84%
3 Financials 8.13%
4 Consumer Staples 8.02%
5 Industrials 7.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPRT
2701
Westport Fuel Systems
WPRT
$35.7M
$108K ﹤0.01%
+4,137
New +$87.2K
WPG
2702
DELISTED
Washington Prime Group Inc.
WPG
$108K ﹤0.01%
+1,264
New +$103K
NCV
2703
Virtus Convertible & Income Fund
NCV
$390M
$106K ﹤0.01%
+4,779
New +$96.7K
QCOM icon
2704
CALL
Qualcomm
QCOM
$176B
$106K ﹤0.01%
+52,800
New +$2.57M
ATW
2705
DELISTED
Atwood Oceanics
ATW
$106K ﹤0.01%
+11,573
New +$87.3K
PFX icon
2706
PhenixFIN
PFX
$90M
$105K ﹤0.01%
+798
New +$102K
RGC
2707
CALL
DELISTED
Regal Entertainment Group
RGC
$105K ﹤0.01%
+60,100
New +$1.15M
FLWS icon
2708
1-800-Flowers.com
FLWS
$258M
$103K ﹤0.01%
+13,100
New +$98.1K
WSCI
2709
DELISTED
WSI Industries Inc
WSCI
$100K ﹤0.01%
+29,500
New +$114K
LINE
2710
DELISTED
LINN ENERGY LLC COM UTS REP LTD LIABILITY CO INTS
LINE
$99K ﹤0.01%
276,345
-42,799
-13% -$35.4K
EXC icon
2711
CALL
Exelon
EXC
$47B
$96K ﹤0.01%
+104,309
New +$2.34M
REFR icon
2712
Research Frontiers
REFR
$17M
$96K ﹤0.01%
+21,000
New +$94.1K
INVN
2713
DELISTED
Invensense Inc
INVN
$96K ﹤0.01%
+11,400
New +$90.5K
JEQ
2714
DELISTED
abrdn Japan Equity Fund
JEQ
$95K ﹤0.01%
+12,880
New +$90.9K
PNNT
2715
Pennant Park Investment Corp
PNNT
$241M
$95K ﹤0.01%
+15,712
New +$89.7K
CLMS
2716
DELISTED
Calamos Asset Management, Inc.
CLMS
$94K ﹤0.01%
+11,056
New +$98.1K
MSFT icon
2717
CALL
Microsoft
MSFT
$3.71T
$93K ﹤0.01%
+128,800
New +$6.75M
MT icon
2718
ArcelorMittal
MT
$55.3B
$92K ﹤0.01%
+6,727
New +$65K
BIOA
2719
DELISTED
BioAmber Inc.
BIOA
$92K ﹤0.01%
+21,950
New +$92.1K
SWK icon
2720
CALL
Stanley Black & Decker
SWK
$15.7B
$91K ﹤0.01%
+10,300
New +$1,000K
ERF
2721
DELISTED
Enerplus Corporation
ERF
$91K ﹤0.01%
+23,261
New +$72.2K
NMBL
2722
DELISTED
Nimble Storage, Inc.
NMBL
$91K ﹤0.01%
11,547
-11,196
-49% -$79.6K
INO icon
2723
Inovio Pharmaceuticals
INO
$69M
$90K ﹤0.01%
+858
New +$66.2K
CYTK icon
2724
Cytokinetics
CYTK
$10.4B
$89K ﹤0.01%
+12,616
New +$92.2K
PIM
2725
Franklin Master Intermediate Income Trust
PIM
$151M
$89K ﹤0.01%
+20,167
New +$86.5K

Similar funds

Raymond James & Associates's Q1 2016 Portfolio in Review

As of Q1 2016, Raymond James & Associates held 3,030 positions worth $29.6B, up 5.8% from $27.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $1.32B of net new capital in Q1 2016, opening 705 new positions and adding to 1,212 existing holdings. Its largest new stake was FlexShares Quality Dividend Index Fund: 874,910 shares worth $31.6M.

By sector, the portfolio is most concentrated in Healthcare at 9% of assets, down from 9.6% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $147M trimmed.

  • Raymond James & Associates's largest Q1 2016 buy was FlexShares Quality Dividend Index Fund: 874,910 shares worth $31.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2016, an estimated $132M increase.
  • Raymond James & Associates's biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $147M.
  • Raymond James & Associates fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $56.9M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $29.6B portfolio in Q1 2016.
  • Raymond James & Associates opened 705 new positions and closed 103 in Q1 2016.
  • Raymond James & Associates's portfolio value rose 5.8% quarter-over-quarter to $29.6B.

Based on Raymond James & Associates's 13F filing for Q1 2016, filed 12 May 2016.